Sage Therapeutics Inc. (SAGE)
7.13
-0.07 (-0.97%)
At close: Mar 04, 2025, 9:55 AM
Sage Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -0.82 | -2.39 | -4.49 | -5.54 | 7.42 | -5.64 | -11.85 | -23.23 | -10.75 | -17.14 | -23.35 | -27.62 | -52.42 |
| PEG Ratio | 0.03 | -0.36 | -0.43 | 0.03 | -0.04 | -0.1 | -0.85 | -0.47 | -0.27 | -0.15 | -0.53 | -0.3 | n/a |
| PS Ratio | 8.00 | 15.00 | 294.29 | 395.66 | 4.04 | 534.32 | 48.94 | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 0.71 | 1.62 | 1.81 | 1.44 | 2.17 | 3.88 | 5.12 | 13.20 | 4.64 | 9.32 | 6.48 | -16.01 | -37.7 |
| P/FCF Ratio | -1.23 | -2.4 | -4.91 | -6.59 | 6.77 | -6.87 | -16.76 | -28.44 | -14.23 | -22.85 | -29.06 | -28.82 | -55.87 |
| P/OCF Ratio | -1.23 | -2.4 | -4.92 | -6.6 | 6.77 | -6.94 | -16.95 | -28.62 | -14.4 | -22.91 | -29.2 | -28.83 | -56.57 |
| OCF/S Ratio | -6.48 | -6.25 | -59.85 | -59.95 | 0.60 | -76.98 | -2.89 | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 7.42 | 10.49 | 13.47 | 21.35 | 31.58 | 9.23 | 10.98 | 10.11 | 11.45 | 12.31 | 16.61 | 3.63 | 1.99 |
| Current Ratio | 7.42 | 10.51 | 12.82 | 21.14 | 31.58 | 9.23 | 10.98 | 10.11 | 11.45 | 12.31 | 16.61 | 3.63 | 1.99 |
| Asset Turnover | 0.08 | 0.10 | 0.01 | 0.00 | 0.52 | 0.01 | 0.09 | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | -38.55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.23K | n/a | n/a |
| Return on Equity (ROE) | -0.86 | -0.68 | -0.4 | -0.26 | 0.29 | -0.69 | -0.43 | -0.57 | -0.43 | -0.54 | -0.28 | 0.58 | 0.72 |
| Return on Assets (ROA) | -0.73 | -0.61 | -0.37 | -0.25 | 0.28 | -0.6 | -0.39 | -0.51 | -0.39 | -0.5 | -0.26 | -2.14 | -3.22 |
| Return on Capital (ROIC) | -0.91 | -0.73 | -0.44 | -0.26 | 0.28 | -0.73 | -0.45 | -0.57 | -0.43 | -0.54 | -0.28 | -2.94 | -6.11 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 77.10% | 97.50% | 89.42% | 91.23% | 99.95% | 94.18% | 98.78% | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -971.48% | -626.32% | -6.55K% | -7.15K% | 54.40% | -9.47K% | -413.06% | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -971.48% | -626.32% | -6.93K% | -7.26K% | 54.40% | -9.9K% | -413.06% | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -1.05K% | -670.69% | -7.12K% | -7.31K% | 53.51% | -10.31K% | -435.61% | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -647.85% | -625.92% | -6K% | -6K% | 59.59% | -7.78K% | -291.93% | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -992.86% | -630.47% | -7.1K% | -7.24K% | 56.24% | -10.28K% | -434.34% | n/a | n/a | n/a | n/a | n/a | n/a |